Although the MSI-CIN cluster was not associated with lower survival, we confirm that MSI-CIN patients with a high expression of MAP4K4 represent a subgroup with very adverse risk (Figure 3F). This evidence concerns the gene MAP4K4 and cervical squamous intraepithelial neoplasia.